Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro
about
Double or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallelUse of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart LesionsEmerging Tools for Stroke Prevention in Atrial FibrillationThe case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit-risk ratioEuropean Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyNew Oral Anticoagulants in Nonvalvular Atrial FibrillationAntithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulationStroke Prevention in Atrial Fibrillation: Focus on Latin AmericaEvaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.[National disease management guidelines (NVL) for chronic CAD : What is new, what is particularly important?].Direct oral anticoagulants in atrial fibrillation: can data from randomized clinical trials be safely transferred to the general population? Yes.Synergic impact of oral anticoagulation control and renal function in determining major adverse events in atrial fibrillation patients undergoing percutaneous coronary intervention: insights from the AFCAS registry.Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registryAntithrombotic therapy for long-term secondary prevention of acute coronary syndrome in high-risk patients.Direct oral anticoagulants: key considerations for use to prevent stroke in patients with nonvalvular atrial fibrillation.Can venous thromboembolism navigate the prevention of cardiovascular complications?Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionManagement of the patient with an acute coronary syndrome using oral anticoagulation.Should a prolonged duration of dual anti-platelet therapy be recommended to patients with diabetes mellitus following percutaneous coronary intervention? A systematic review and meta-analysis of 15 studies.The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulantsMonitoring the Effects and Antidotes of the Non-vitamin K Oral Anticoagulants.Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF-TIMI48 Trial.Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants.The effect of a dual or a triple antithrombotic therapy with apixaban on thrombus formation in vivo and in an ex vivo perfusion chamber model: An open-label, controlled, sequential study.Resolution of left ventricular postinfarction thrombi in patients undergoing percutaneous coronary intervention using rivaroxaban in addition to dual antiplatelet therapy.Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial FiUse of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary InterventionTriple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention - real life assessment.Risk factors associated with bleeding after multi antithrombotic therapy during implantation of cardiac implantable electronic devices.Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.The year in cardiology 2014: arrhythmias and device therapy.Choosing the right drug to fit the patient when selecting oral anticoagulation for stroke prevention in atrial fibrillation.Pharmacodynamic profile and drug interactions with non-vitamin K antagonist oral anticoagulants: implications for patients with atrial fibrillation.Minimizing the risk of hemorrhagic stroke during anticoagulant therapy for atrial fibrillation.Risks and benefits of triple oral anti-thrombotic therapies after acute coronary syndromes and percutaneous coronary intervention.Effective practical management of patients with atrial fibrillation when using new oral anticoagulants.Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.Antiplatelet Therapy During PCI for Patients with Stable Angina and Atrial Fibrillation.Triple therapy for percutaneous coronary intervention in atrial fibrillation: standard of care, or a nightmare soon to end?Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.
P2860
Q26741058-3A9F6215-F4A4-4047-9044-47230C0615B4Q26764853-EA5B0F01-840E-434B-B04F-107ABF4BF242Q26765023-B5CBDB8B-8A8C-40CC-B207-24663B5B2522Q26776239-233500F0-F81A-458A-9A85-D8AA02032547Q26796261-865EAC91-6F01-4ECC-A01C-65CEB7AEAE90Q28066141-3330C5BE-C9C0-4579-AFFD-5797B8247986Q28072522-9C69089D-79FF-4F79-99E2-DB5E874C84CAQ28359631-684C69AC-9C60-4C4A-A7C9-412EBE1A0E92Q30252099-A4E118DC-931B-451C-8EED-3FB1A3658DD0Q30313892-DBEFC196-C17B-47B4-AA66-2CBD79ABFC46Q30979197-794EC5B7-02B4-405B-AEB6-65E3245010ABQ33720574-6D8E4923-9427-432D-B551-4AEDD6C7CDC2Q33817357-473479CA-9A26-48EB-BF31-3573CF4066F5Q35111496-9A042272-24E5-4353-8C1B-284E7FA34F6DQ35746798-D2FDCE7F-36C0-4234-B45C-8A694F9ED9FEQ35783633-BAEE920B-1FBD-4BFD-BF90-CA96F48BF2A1Q35903857-4AC9A3B6-C28D-467C-A05C-CF88A8DC357DQ35991815-D80C781D-C14D-4370-97CC-EAA3C54C5CFFQ36117653-0D862802-EFF9-4E56-9940-9D13F0A8D69FQ36396649-A17BBA58-7110-452E-B64D-9257554F7F5CQ36458797-B291F6C8-F4EC-4701-B68A-B019090F4E28Q36713982-4C45E774-6B43-4976-AB54-80261EFB2D26Q36874702-A8E2141C-9B7C-4707-9E9C-18BD61CC8728Q37328158-361194BE-F783-4C7D-A403-259217946F06Q37390016-E12C3AC1-A5F5-4299-A2C3-D74F82C36FC2Q37412869-BB960A79-EBF8-4FD7-8AE0-0B1E8B69CBC0Q37434813-76423C81-FA68-4C44-BDFD-A15C35ECDF61Q37463805-FD8E45D7-F1B1-4081-975B-727F923B7F5EQ37677988-0BE6ABC1-ECAA-4C2F-A9F1-48813688D3D0Q38262325-53FFF6F3-1365-4552-BB16-9C148D392B45Q38307425-EFCC694C-7F2F-4E05-A53B-3952EB88A1AEQ38372780-7D4D085F-728E-4074-BB41-A6AC13A9BA48Q38386660-C1699EAC-01EC-4540-913A-1F0DA9516177Q38389058-1D215FCA-5459-48A6-BBF6-D937DEB8EDB3Q38398587-E26E8060-A482-4D65-AA74-BEE96395BB06Q38409730-8A310590-3086-4B77-8617-281E60CD8E56Q38496232-98FA8462-96CD-4F39-B652-98373292BFD0Q38535999-FEE29F75-5655-48D2-8B84-7F484C418FE7Q38543313-54D2BA82-CCDB-448A-BEF1-B557F0F717C2Q38545163-468601CA-EF1E-4D32-B22D-A8E7A4932BE8
P2860
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Management of antithrombotic t ...... iety of Cardiology Working Gro
@en
type
label
Management of antithrombotic t ...... iety of Cardiology Working Gro
@en
prefLabel
Management of antithrombotic t ...... iety of Cardiology Working Gro
@en
P2093
P50
P356
P1476
Management of antithrombotic t ...... iety of Cardiology Working Gro
@en
P2093
Andrea Rubboli
Christian Mueller
Deirdre Lane
Document Reviewers
Francisco Marin
Jean-Philippe Collet
Joao Morais
Jose L Zamorano
Jurriën M Ten Berg
Karl Georg Haeusler
P304
P356
10.1093/EURHEARTJ/EHU298
P50
P577
2014-08-25T00:00:00Z